Calcium 用于 高血压
C 证据 来自小型研究的证据有限，但存在一些积极信号。Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'heartcited.com';
const params = 'ingredient\u003Dcalcium\u0026condition\u003Dhigh\u002Dblood\u002Dpressure';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
结论
Small meta-analytic BP reduction (-1.4 mmHg systolic). Overwhelmed by cardiovascular safety concerns from supplement studies. Dietary calcium preferred.
Key Study Findings
Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None
vs: Standard care or placebo
Outcome: Global cognition in stroke survivors
效果: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins)
0.009 (protein); 0.02 (B-vit)
研究人群: Adult stroke survivors (20 trials + 14 observational)
Review
Dietary supplements and prevention of preeclampsia.
Dose: 500 mg daily
vs: Placebo
Outcome: Preeclampsia risk reduction
效果: ~50% risk reduction
None
研究人群: Pregnant women with low calcium intake
Review
Novel pharmacologic approaches in resistant hypertension.
Dose: Spironolactone, sacubitril/valsartan, SGLT2i
vs: None
Outcome: Blood pressure control in resistant HTN
效果: None
None
研究人群: Patients with resistant hypertension
Review
Vegan Diet Health Benefits in Metabolic Syndrome.
Dose: None
vs: None
Outcome: None
效果: None
None
研究人群: Adults with metabolic syndrome
cross-sectional observational study
n=260
Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers.
Dose: None
vs: Placebo
效果: None
None
Observational Study
n=40
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Dose: anti-digoxin antibodies (Fab)
vs: pre-treatment
Outcome: serum digoxin and clinical outcomes
效果: Fab bound digoxin; no improved clinical outcomes
None
研究人群: Chronic digoxin toxicity patients
Key Statistics
13
研究数量
1500
受试者
↔
Mixed
C
等级
Referenced Papers
Hypertension research : …
2025
10 次引用
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Meta-Analysis
Advances in nutrition …
2025
1 次引用
Wiadomosci lekarskie (Warsaw, …
2024
Nutrients
2021
113 次引用
Journal of renal …
2017
26 次引用
Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1).
Observational
Clinical toxicology (Philadelphia, …
2016
25 次引用
Trends in cardiovascular …
2016
19 次引用
Nephro-urology monthly
2014
43 次引用
Zhongguo Zhong yao …
2014
4 次引用
British journal of …
2013
156 次引用
Acta medica Indonesiana
2007
4 次引用
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- note:
- Prefer dietary sources; limit supplements to 500 mg/dose
- general:
- 1,000-1,200 mg/day from diet plus supplements
上限： 2,000-2,500 mg/day (total from diet and supplements)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| 500 mg daily | -- | Positive | -- |
| Spironolactone, sacubitril/valsartan, SGLT2i | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Neutral | 260 |
| anti-digoxin antibodies (Fab) | -- | Neutral | 40 |
| None | -- | Mixed | -- |
| None | -- | Neutral | 2991 |
最佳服用时间： Divide doses (500 mg max per dose); carbonate with meals; citrate any time
Safety & Side Effects
已报告的副作用
- ⚠ Constipation (especially carbonate form)
- ⚠ Potential increased MI risk with high-dose supplements (controversial)
- ⚠ Kidney stones at excessive doses
- ⚠ Gas, bloating
已知相互作用
- ● Thyroid medications (separate by 4 hours)
- ● Bisphosphonates (separate by 30-60 minutes)
- ● Iron supplements (reduced absorption — separate by 2 hours)
- ● Certain antibiotics (reduced absorption)
- ● Vitamin K2 (may help direct supplemental calcium to bones, not arteries)
可耐受最高摄入量： 2,000-2,500 mg/day (total from diet and supplements)
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Calcium help with 高血压?
Based on 13 studies with 1,500 participants, there is limited but promising evidence that Calcium may support 高血压 management. Our evidence grade is C (Some Evidence).
How much Calcium should I take for 高血压?
Studies have used various dosages. A commonly studied range is Prefer dietary sources; limit supplements to 500 mg/dose. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Calcium?
Reported side effects may include Constipation (especially carbonate form), Potential increased MI risk with high-dose supplements (controversial), Kidney stones at excessive doses, Gas, bloating. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Calcium and 高血压?
We rate the evidence as Grade C (Some Evidence). This rating is based on 13 peer-reviewed studies with 1,500 total participants. The overall direction of effect is mixed.
Related Evidence
References
- [1] Takafumi Ushida et al.. Hypertens Res. 2025. Dietary supplements and prevention of preeclampsia. doi:10.1038/s41440-025-02144-9 PubMed
- [2] Sasan Amanat et al.. Adv Nutr. 2025. Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis. doi:10.1016/j.advnut.2025.100440 PubMed
- [3] Jerzy Głuszek. Wiad Lek. 2024. Novel pharmacologic approaches in resistant hypertension. doi:10.36740/WLek/194090 PubMed
- [4] Giulia Marrone et al.. Nutrients. 2021. Vegan Diet Health Benefits in Metabolic Syndrome. doi:10.3390/nu13030817 PubMed
- [5] Niloufar Zadeh Saraji et al.. J Renal Inj Prev. 2017. Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. doi:10.15171/jrip.2017.27 PubMed
- [6] Betty S Chan et al.. Clin Toxicol (Phila). 2016. Efficacy and effectiveness of anti-digoxin antibodies in chronic digoxin poisonings from the DORA study (ATOM-1). doi:10.1080/15563650.2016.1175620 PubMed
- [7] Alfonso Eirin et al.. Trends Cardiovasc Med. 2016. Emerging concepts for patients with treatment-resistant hypertension. doi:10.1016/j.tcm.2016.05.004 PubMed
- [8] Behzad Einollahi et al.. Nephrourol Mon. 2014. Restless leg syndrome: a neglected diagnosis. doi:10.5812/numonthly.22009 PubMed
- [9] Jian-hong Li et al.. Zhongguo Zhong Yao Za Zhi. 2014. [Clinical characteristics and combined use of medicine analysis of 2 991 hospitalized patients with psoriasis based on real world database]. PubMed
- [10] S Basit. Br J Biomed Sci. 2013. Vitamin D in health and disease: a literature review. doi:10.1080/09674845.2013.11669951 PubMed
- [11] Eka Ginanjar et al.. Acta Med Indones. 2007. Vitamin D and autoimmune disease. PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。